HIV/Hepatitis External Quality Assessment
The RIQAS HIV/Hepatitis EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for qualitative methods of analysis.
- Liquid ready-to-use
- 100% human plasma
- Quarterly reporting (5 samples per quarterly distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
*Please note, that as of July 2021 (Cycle 10), there will be some exciting changes to the format of this programme. From July 2021, this programme will move to a monthly reporting format and will be distributed twice per year. There will be 2 samples to run each month, totaling 24 over the full cycle. We are also pleased to confirm that the parameter list will be extended to include: Anti-HAV IgM, Anti-HAV (Total), Anti-HBc IgM, Anti-HBe (Total), Anti-HBs (Total) and P24.*
- Anti-HTLV-1&2 (combined)
- Anti-HIV-1&2 (combined)
Please note, product availability may vary country to country.